# SGLT2 Inhibitors

SGLT2 inhibitors lower blood glucose by increasing urinary glucose excretion through the kidneys.

They also provide cardiovascular and renal benefits in certain patient populations.

## Clinical Use
- Used in Type 2 diabetes
- May reduce cardiovascular risk
- Requires monitoring of renal function

## Example
- Empagliflozin
